losartan-potassium and Splenic-Diseases

losartan-potassium has been researched along with Splenic-Diseases* in 2 studies

Reviews

1 review(s) available for losartan-potassium and Splenic-Diseases

ArticleYear
Peliosis of the spleen: possible association with chronic renal failure and erythropoietin therapy.
    Postgraduate medical journal, 1995, Volume: 71, Issue:838

    Splenic peliosis was identified at necropsy in a 62-year-old woman receiving continuous ambulatory peritoneal dialysis for end-stage renal failure, and erythropoietin therapy for uraemia and anaemia. The immediate cause of death was arrhythmia related to ischaemic heart disease, following an episode of intramuscular haematoma (secondary to platelet dysfunction). The unusual association between peliosis and renal failure, and possibly erythropoietin therapy, is discussed.

    Topics: Anemia; Erythropoietin; Fatal Outcome; Female; Hematoma; Humans; Kidney Failure, Chronic; Middle Aged; Splenic Diseases; Uremia

1995

Other Studies

1 other study(ies) available for losartan-potassium and Splenic-Diseases

ArticleYear
Spontaneous splenic rupture caused by splenic peliosis of a hemodialysis patient with chronic renal failure receiving erythropoietin.
    The American journal of emergency medicine, 2008, Volume: 26, Issue:1

    Topics: Abdominal Pain; Cysts; Dilatation, Pathologic; Erythropoietin; Hematoma; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Rupture, Spontaneous; Spleen; Splenectomy; Splenic Diseases; Splenic Rupture; Splenomegaly; Tomography, X-Ray Computed

2008